Dr. Kelesidis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5323 Harry Hines Blvd
Dallas, TX 75390Phone+1 310-825-7225Fax+1 213-861-5863- Is this information wrong?
Education & Training
- University of California Los AngelesMsc, Translational Research , Cum Laude, 2015 - 2016
- University of California Los AngelesPhD, Microbiology, Immunology, Molecular Genetics, Cum Laude, 2010 - 2013
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Infectious Disease, 2009 - 2013
- St Elizabeth's Medical CenterResidency, Internal Medicine, 2006 - 2009
- Beth Israel Deaconess Medical CenterEndocrinology, Metabolism , 2005 - 2006
- University of AthensClass of 2004, MD, Cum Laude
Certifications & Licensure
- TX State Medical License 2023 - 2024
- CA State Medical License 2009 - 2024
- MA State Medical License 2008 - 2015
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Relative Mitochondrial Toxicity of Tenofovir Alafenamide (TAF) vs. Tenofovir Disoproxil Fumarate (TDF) Start of enrollment: 2019 Apr 01
- Doravirine Versus Integrase Inhibitors on Backbone of Emtricitabine and Tenofovir Alafenamide in HIV Start of enrollment: 2024 Mar 01
Roles: Contact, Principal Investigator
- An Open Label Study in Adults to Test the Efficacy of Mitoquinone/Mitoquinol Mesylate to Prevent Severe Viral Illness Start of enrollment: 2022 Apr 28
Roles: Principal Investigator, Contact
- Join now to see all
Publications & Presentations
PubMed
- Mitoquinone mesylate as post-exposure prophylaxis against SARS-CoV-2 infection in humans: an exploratory single center pragmatic open label non-randomized pilot clinic...Keren Chen, Nicholas J Jackson, Theodoros Kelesidis> ;Ebiomedicine. 2024 Apr 1
- Single-Cell Profiling of the Differential In Vivo Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Lung Tissue Cell Subtypes at the Protein Le...Fotooh Abadi, L., Sharma, M., Kelesidis, T., Kelesidis, T.> ;The Journal of Infectious Diseases. 2024 Jan 12
- HIV and COVID-19: two pandemics with significant (but different) central nervous system complications.Shino Magaki, Ting Zhang, Karam Han, Mirbaha Hilda, William H Yong, Cristian Achim, Gregory Fishbein, Michael C Fishbein, Omai Garner, Noriko Salamon, Christopher K Wi...> ;Free Neuropathology. 2024 Jan 1
- Join now to see all
Press Mentions
- Urgent Warning as Study Finds Vaping Could Put Healthy Young People at Higher Risk of Developing a Severe DiseaseFebruary 10th, 2023
- Smoking Tobacco, Vaping E-cigarettes May Raise Risk of COVID-19 in Healthy Young People, Says StudyFebruary 10th, 2023
- Vaping Could Raise Teens' Odds for Severe COVIDFebruary 10th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: